Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ReShape Lifesciences Inc. (NASDAQ: RSLS).

Full DD Report for RSLS

You must become a subscriber to view this report.


Recent News from (NASDAQ: RSLS)

ReShape Lifesciences Announces 1-for-140 Reverse Stock Split
SAN CLEMENTE, CA / ACCESSWIRE / November 7, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that its Board of Directors has declared a 1-for-140 reverse stock split of the company's co...
Source: ACCESSWIRE
Date: November, 07 2018 08:00
ReShape Lifesciences to Host Third Quarter 2018 Conference Call on November 14, 2018
SAN CLEMENTE, CA / ACCESSWIRE / October 31, 2018 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that it will host a conference call to discuss financial results for the third quarter 2018 o...
Source: ACCESSWIRE
Date: October, 31 2018 08:00
ReShape Lifesciences Announces Retirement of Series D Preferred Stock
SAN CLEMENTE, CA / ACCESSWIRE / October 29, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that as of Friday, October 19, 2018, all shares of the Company's Series D Preferred Stock ha...
Source: ACCESSWIRE
Date: October, 29 2018 08:00
ReShape Lifesciences Announces Attendance and Presentation at ObesityWeek 2018
SAN CLEMENTE, CA / ACCESSWIRE / October 25, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the Company will be exhibiting its products and will be the subject of a poster present...
Source: ACCESSWIRE
Date: October, 25 2018 08:00
ReShape Lifesciences Announces New Patent Grant Expanding its Gastric Vest Patent Portfolio
SAN CLEMENTE, CA / ACCESSWIRE / September 6, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that The State Intellectual Property Office of The People's Republic of China has granted a...
Source: ACCESSWIRE
Date: September, 06 2018 08:00
ReShape Lifesciences to Present at H.C. Wainwright 20th Annual Global Investment Conference
SAN CLEMENTE, CA / ACCESSWIRE / August 24, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the company will be participating in the upcoming H.C. Wainwright 20th Annual Global Investme...
Source: ACCESSWIRE
Date: August, 24 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-140.05970.0580.0620.0543,259,546

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1069,173162,63842.5319Short
2018-12-07114,484194,57358.8386Short
2018-12-0688,050213,81741.1801Short
2018-12-04142,176303,00646.9218Short
2018-12-0388,253217,20240.6318Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RSLS.


About ReShape Lifesciences Inc. (NASDAQ: RSLS)

Logo for ReShape Lifesciences Inc. (NASDAQ: RSLS)

Not available

 

Contact Information

 

 

Current Management

  • Mark Knudson / CEO
  • Greg Lea / CFO

Current Share Structure

  • Market Cap: $11,813,234 - 05/18/2018
  • Issue and Outstanding: 30,957,113 - 02/28/2018

 


Recent Filings from (NASDAQ: RSLS)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 28 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: August, 22 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 20 2018
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 13 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: August, 10 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: August, 09 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: August, 07 2018

 

 


Daily Technical Chart for (NASDAQ: RSLS)

Daily Technical Chart for (NASDAQ: RSLS)


Stay tuned for daily updates and more on (NASDAQ: RSLS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: RSLS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RSLS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RSLS and does not buy, sell, or trade any shares of RSLS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/